Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
Research add new data to diabetes therapy body of knowledge
December 29th, 2005
New findings from Japan, the South Korea and the United Kingdom describe advances in diabetes therapy. Study 1: Patients with nonalcoholic steatohepatitis (NASH) and type 2 diabetes benefit from nateglinide. "In the present study we administered nateglinide to NASH patients with type 2 diabetes who had failed to respond adequately to diet and exercise therapy, and we compared the resulting changes in insulin kinetics and improvements in blood glucose levels, as well as the concomitant changes in hepatic function, diagnostic liver images and liver histology, with the results from a non-treated control group," investigators in Japan report. ...
Source: Blood Weekly (2005-12-29)
|
